Open AccessReclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa : Implications for patients with cystic fibrosis (CF)
Author(s) -
Millar Beverley Cherie,
Malnarcic Camila M.,
McCaughan John,
Moore John E.
Publication year - 2020
Publication title -
the clinical respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 33
eISSN - 1752-699X
pISSN - 1752-6981
DOI - 10.1111/crj.13100
Subject(s) - northern ireland , medicine , bacteriology , public health , levofloxacin , library science , family medicine , history , pathology , microbiology and biotechnology , ethnology , biology , genetics , bacteria , antibiotics , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom